NAD (P) H Quinine Oxidoreductase (NQO1) as a Risk Modifier of Susceptibility to Polycythaemia Vera in Sudan

International Journal of Biomedical Research
doi 10.7439/ijbr.v6i6.2017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Scholar Science Journals

Related search

A Polymorphism in NAD(P)H:quinone Oxidoreductase (NQO1): Relationship of a Homozygous Mutation at Position 609 of the NQO1 cDNA to NQO1 Activity

British Journal of Cancer
Cancer ResearchOncology
1996English

Association of NAD(P)H Quinine Oxidoreductase 1 Rs1800566 Polymorphism With Bladder and Prostate Cancers – A Systematic Review and Meta-Analysis

Klinicka Onkologie
Oncology
2020English

NAD(P)H: FMN-oxidoreductase Functioning Under Macromolecular Crowding: In Vitro Modeling

Доклады Академии наук
2019English

Identification of a Cytochrome B-Type NAD(P)H Oxidoreductase Ubiquitously Expressed in Human Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

Hyperuricaemia in Polycythaemia Vera

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1966English

Peripheral Gangrene in Polycythaemia Vera

Postgraduate Medical Journal
Medicine
1975English

Induction of NAD(P)H:Quinone Oxidoreductase 1 (NQO1) byGlycyrrhizaSpecies Used for Women’s Health: Differential Effects of the Michael Acceptors Isoliquiritigenin and Licochalcone A

Chemical Research in Toxicology
MedicineToxicology
2015English

NAD(P)+-NAD(P)H Models. 72. Isotope Effects to Prove the Multi-Step Mechanism in the Reduction With an NAD(P)H Analog

Bulletin of the Chemical Society of Japan
Chemistry
1990English

Copper (II) Binding of NAD(P)H- Flavin Oxidoreductase (NfoR) Enhances Its Cr (VI)-reducing Ability

Scientific Reports
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy